Condition

Abdominal Aortic Aneurysm

ClinicalTrials.gov condition label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 17 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials17

Recruiting1

Common interventions10

Lead sponsors shown9

Clinical trials

17 shown

Epidemiology of Abdominal Aortic Aneurysm With Concomitant Primary Lung CancerNCT06775821 · 2022-10-01

Pilot Study on the Effectiveness and Safety of OPTILENE® SILVER MESH ELASTIC in Prevention of Surgical Site Infection (SSI) and Incisional Hernia (IH)NCT06547138 · 2026-09-01

NOT_YET_RECRUITING

EQUITA - A Feasibility Trial of a Faith-placed Intervention to Increase Screening Uptake in Black AdultsNCT06981182 · 2025-09-01

NOT_YET_RECRUITING

Evaluation of the Impact of Prehabilitation on Recovery Following Open Surgery for Abdominal Aortic AneurysmNCT05375292 · 2022-12-06

Evaluation of Implementation of a National Point-of-Care Ultrasound Training ProgramNCT03296280 · 2016-10-03

Understanding the Role of Autoimmune Disorders on the Initial Presentation of Cardiovascular DiseaseNCT02062021 · 2014-01-01

Ethnicity and Onset of Cardiovascular Disease: A CALIBER StudyNCT02176174 · 2013-12-01

Social Deprivation and Initial Presentation of 12 Cardiovascular Diseases: a CALIBER StudyNCT01937065 · 2012-01-01

Heart Rate and Initial Presentation of Cardiovascular Diseases (Caliber)NCT01947361 · 2012-01-01

Study on Anti-inflammatory Effect of Anti-hypertensive Treatment in Patients With Small AAA's and Mild HypertensionNCT01425242 · 2011-09-01

Screening for Abdominal Aortic Aneurysm and Abdominal Aortic Atherosclerosis by Hand-Held UltrasonographyNCT01679288 · 2011-01-01

Telesonography Adaptation and Use to Improve the Standard of Patient Care Within a Dominican CommunityNCT00591968 · 2008-01-01

Body Mass Index and Initial Presentations of Cardiovascular DiseasesNCT01704300 · 2001-01-01

Serum Uric Acid Levels and Onset of Cardiovascular Diseases: a CALIBER StudyNCT03425305 · 1998-01-01

White Blood Cell Counts and Onset of Cardiovascular Diseases: a CALIBER StudyNCT02014610 · 1997-01-01

The Role of Alcohol Consumption in the Aetiology of Different Cardiovascular Disease Phenotypes: a CALIBER StudyNCT01864031 · 1997-01-01

Risk Factors in the Initial Presentation of Specific Cardiovascular Disease SyndromesNCT01804439 · 1997-01-01

Common interventions

AliskirenDRUG1 AmlodipineDRUG1 Faith-placed intervention to promote breast, cervical, bowel, and AAA screening uptake in Black communities.OTHER1 No interventionOTHER1 No treatmentOTHER1 PREHABILITATIONOTHER1 Prophylactic meshDEVICE1 SonoSite Titan portable ultrasound coupled with email telediagnosisDEVICE1 Ultrasound (Trademark:VScan; Manufacturer:General Electrics)DEVICE1 Ultrasound or CT of the abdominal aortaDEVICE1

Mapped drugs appearing in these trials

Shared trial participation only; not evidence of efficacy or approval.

aliskiren1 amlodipine1

Leading sponsors

University College, London 9 Aesculap AG 1 Amsterdam UMC, location VUmc 1 Consorci d'Atenció Primària de Salut de l'Eixample 1 Edward Via Virginia College of Osteopathic Medicine 1 First Affiliated Hospital of Kunming Medical University 1 University Hospital, Toulouse 1 University of Sunderland 1 VA Office of Research and Development 1

Trial status mix

UNKNOWN7

COMPLETED6

NOT_YET_RECRUITING2

RECRUITING1

TERMINATED1

Phase mix

NA5

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.